Clinical Trial Update: Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy, safety, and immune effects of tofacitinib in treating Primary Sjögren's Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: UNKNOWN